Authors:
Hobisch, A
Ramoner, R
Fuchs, D
Godoy-Tundidor, S
Bartsch, G
Klocker, H
Culig, Z
Citation: A. Hobisch et al., Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype, CLIN CANC R, 7(9), 2001, pp. 2941-2948
Authors:
Holtl, L
Eder, IE
Klocker, H
Hobisch, A
Bartsch, G
Stenzl, A
Citation: L. Holtl et al., Photodynamic diagnosis with 5-aminolevulinic acid in the treatment of secondary urethral tumors: First in vitro and in vivo results, EUR UROL, 39(2), 2001, pp. 178-182
Authors:
Doppler, W
Windegger, M
Soratroi, C
Tomasi, J
Lechner, J
Rusconi, S
Cato, ACB
Almlof, T
Liden, J
Okret, S
Gustafsson, JA
Richard-Foy, H
Starr, DB
Klocker, H
Edwards, D
Geymayer, S
Citation: W. Doppler et al., Expression level-dependent contribution of glucocorticoid receptor domainsfor functional interaction with STAT5, MOL CELL B, 21(9), 2001, pp. 3266-3279
Authors:
Rimler, A
Culig, Z
Levy-Rimler, G
Lupowitz, Z
Klocker, H
Matzkin, H
Bartsch, G
Zisapel, N
Citation: A. Rimler et al., Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity, PROSTATE, 49(2), 2001, pp. 145-154
Authors:
Bartsch, G
Horninger, W
Klocker, H
Reissigl, A
Oberaigner, W
Schonitzer, D
Severi, G
Robertson, C
Boyle, P
Citation: G. Bartsch et al., Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria, UROLOGY, 58(3), 2001, pp. 417-424
Authors:
Horninger, W
Volgger, H
Rogatsch, H
Strohmeyer, D
Steiner, H
Hobisch, A
Klocker, H
Bartsch, G
Citation: W. Horninger et al., Predictive value of total and percent free prostate specific antigen in high grade prostatic intraepithelial neoplasia lesions: Results of the Tyrol Prostate Specific Antigen Screening Project, J UROL, 165(4), 2001, pp. 1143-1145
Authors:
Eder, IE
Culig, Z
Ramoner, R
Thurnher, M
Putz, T
Nessler-Menardi, C
Tiefenthaler, M
Bartsch, G
Klocker, H
Citation: Ie. Eder et al., Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides, CANC GENE T, 7(7), 2000, pp. 997-1007
Authors:
Couzens, M
Liu, M
Tuchler, C
Kofler, B
Nessler-Menardi, C
Parker, RMC
Klocker, H
Herzog, H
Citation: M. Couzens et al., Peptide YY-2 (PYY2) and pancreatic polypeptide-2 (PPY2): Species-specific evolution of novel members of the neuropeptide Y gene family, GENOMICS, 64(3), 2000, pp. 318-323
Authors:
Stenzl, A
Strasser, H
Klima, G
Eder, I
Frauscher, F
Klocker, H
Bartsch, G
Ninkovic, M
Citation: A. Stenzl et al., Reconstruction of the lower urinary tract using autologous muscle transferand cell seeding: current status and future perspectives, WORLD J URO, 18(1), 2000, pp. 44-50
Citation: G. Bartsch et al., Dihydrotestosterone and the concept of 5 alpha-reductase inhibition in human benign prostatic hyperplasia, EUR UROL, 37(4), 2000, pp. 367-380
Authors:
Corvin, S
Boesch, S
Maneschg, C
Radmayr, C
Bartsch, G
Klocker, H
Citation: S. Corvin et al., Effect of heat exposure on viability and contractility of cultured prostatic stromal cells, EUR UROL, 37(4), 2000, pp. 499-504
Authors:
Nessler-Menardi, C
Jotova, I
Culig, Z
Eder, IE
Putz, T
Bartsch, G
Klocker, H
Citation: C. Nessler-menardi et al., Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models, PROSTATE, 45(2), 2000, pp. 124-131
Authors:
Gadenstatter, M
Klingler, A
Klocker, H
Wetscher, GJ
Citation: M. Gadenstatter et al., Long-term results following laparoscopic partial posterior fundoplication in patients with severe gastroesophageal reflux disease, WIEN KLIN W, 112(2), 2000, pp. 70-74
Authors:
Hobisch, A
Hoffmann, J
Lambrinidis, L
Eder, IE
Bartsch, G
Klocker, H
Culig, Z
Citation: A. Hobisch et al., Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model, UROL INTERN, 65(2), 2000, pp. 73-79